Maternal exposure to heparin products and risk of birth defects in the National Birth Defects Prevention Study.
Howley MM, Fisher SC, Van Zutphen AR, Papadopoulos EA, Patel J, Lin AE, Browne ML; National Birth Defects Prevention Study.
Howley MM, et al.
Birth Defects Res. 2023 Jan 15;115(2):133-144. doi: 10.1002/bdr2.2074. Epub 2022 Aug 14.
Birth Defects Res. 2023.
PMID: 36458698
The adjusted ORs ranged from 0.9 to 3.9 and were elevated for anorectal atresia (OR = 2.0, 95% CI = 0.8-4.3), longitudinal limb deficiency (3.5, 1.3-7.8), transverse limb deficiency (1.8, 0.6-4.3), atrioventricular septal defect (3.9, 1.4-9.0), and secundum atrial septa …
The adjusted ORs ranged from 0.9 to 3.9 and were elevated for anorectal atresia (OR = 2.0, 95% CI = 0.8-4.3), longitudinal limb deficiency ( …